Kinetic studies of dopamine D2 receptor molecular pharmacology

QR Code

Kinetic studies of dopamine D2 receptor molecular pharmacology

The dopamine D2 receptor (D2R) is a G protein-coupled receptor (GPCR) that is the primary target of drugs treating the symptoms of Parkinson’s disease and schizophrenia. However, drugs acting at the D2R to manage these diseases often display efficacy for only a subset of their symptoms and have poor...

Full description

Bibliographic Details
Main Author:	Keen, Alastair C.
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2021
Online Access:	https://eprints.nottingham.ac.uk/64380/

Similar Items

Medicinal Chemistry & Chemical Biology Approaches to Investigate Prospective Treatments for CNS Diseases: Dopamine D1 Receptor Positive Allosteric Modulators, Dopamine D2 Receptor Positive & Negative Allosteric Modulators, Dopamine D2 Receptor-Ligand Kinetics
by: Fyfe, Tim
Published: (2019)

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
by: Sykes, David A., et al.
Published: (2017)

Determination of agonist intrinsic efficacies at the dopamine D2 receptor
by: Stott, Lisa Alice
Published: (2017)

D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors
by: Bay-Richter, C., et al.
Published: (2013)

Dopamine D1 receptor involvement in latent inhibition and overshadowing
by: Nelson, Andrew J.D., et al.
Published: (2012)

The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioral changes in a rat neurodevelopmental model for schizophrenia
by: Watson, David J.G., et al.
Published: (2016)

Controlled dopamine (D1) receptor stimulation using photo-responsive substrates
by: Rajput, Sunil
Published: (2019)

A thieno[2,3-d]pyrimidine scaffold is a novel negative allosteric modulator of the dopamine D2 receptor
by: Fyfe, Tim J., et al.
Published: (2018)

The role of dopamine D2 and neuregulin-1 receptors in schizophrenia relevant phenotypes of cognition, attention and memory
by: Mathur, Naina
Published: (2012)

Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
by: Lawford, B., et al.
Published: (2016)

On-Demand Dopamine Receptor Activation via Photoresponsive Nanoparticle-Dopamine Conjugates with an Emphasis on Parkinson’s Disease
by: Alghamdi, Hajar
Published: (2024)

Dopamine D1-like receptor signalling in the hippocampus and amygdala modulates the acquisition of contextual fear conditioning
by: Heath, Florence C., et al.
Published: (2015)

Corticosterone and dopamine D2/D3 receptors mediate the motivation for voluntary wheel running in C57BL/6J mice
by: Ebada, Mohamed Elsaed Elsayed, et al.
Published: (2016)

Discovery of a novel class of negative allosteric modulator of the dopamine D2 receptor through fragmentation of a bitopic ligand
by: Mistry, Shailesh N., et al.
Published: (2015)

Dopamine D1 receptor stimulation modulates the formation and retrieval of novel object recognition memory: role of the prelimbic cortex
by: Pezze, Marie A., et al.
Published: (2015)

Perinatal maternal alcohol consumption and methylation of the dopamine receptor DRD4 in the offspring: the Triple B study
by: Fransquet, P., et al.
Published: (2016)

Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase
by: Wana, Mohammed Nasiru, et al.
Published: (2023)

Genetic analysis of beta 2 adrenergic and Dopamine receptor gene polymorphisms in hypertensive subjects at Hospital Seremban, Malaysia
by: Komara, Makanko
Published: (2013)

An evaluation of DREADD receptor pharmacology in recombinant cells and astrocytes
by: Carpenter, Jessica
Published: (2020)

Prevalence of Hypertension in University Students and Association of Catechol-O Methyltransferase (Val158met) and Dopamine D2 Receptor (Taq1a) Polymorphism with Hypertension
by: Gan, Kelvin
Published: (2016)

Evaluation of the dopamine and serotonin receptor binding activity of selected aporphines / Vani A/P Munusamy
by: Vani, Munusamy
Published: (2012)

Investigations into β2-adrenoceptor pharmacology: kinetic analysis, mechanotransduction and allosteric modulation
by: Cullum, Sean A.
Published: (2024)

Molecular modelling of the cannabinoid receptors: structure-based design, synthesis and pharmacological evaluation of novel ligands based on the fenofibrate scaffold
by: Loo, Jason S. E.
Published: (2015)

Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4
by: Fransquet, P., et al.
Published: (2017)

Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2
by: Peach, Chloe, et al.
Published: (2018)

Pharmacological interactions between phenylbenzothiazoles and aryl hydrocarbon receptor (AhR)
by: Bazzi, Rana
Published: (2008)

Pharmacological characterisation of the fatty acid receptors GPR120 and FFA1
by: Watson, Sarah-Jane
Published: (2013)

Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2) deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?
by: O'Callaghan, M.J., et al.
Published: (2014)

Molecular Probes for P2X7 Receptor Studies
by: Gunosewoyo, Hendra, et al.
Published: (2007)

Molecular pharmacological studies of CHFI-FXII interaction and FXII function
by: Kareem Hamad, B.
Published: (2016)

Design, synthesis and pharmacological evaluation of novel fluorescent ligands for the mu-opioid receptor
by: Marshall, William
Published: (2021)

Angiotensin receptor neprilysin inhibitor LCZ696: Pharmacology, pharmacokinetics and clinical development
by: Hua, Y., et al.
Published: (2017)

Pharmacological analysis and structure determination of 7-methylcyanopindolol–bound b1-adrenergic receptor
by: Sato, Tomomi, et al.
Published: (2015)

The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
by: Brandish, P., et al.
Published: (2014)

Molecular mechanism of DLBS3233 bioactive fraction in type-2 diabetes mellitus: network pharmacology and docking study
by: Tan, Santi, et al.
Published: (2023)

Effects of dopamine D1 modulation of the anterior cingulate cortex in a fear conditioning procedure
by: Pezze, Marie A., et al.
Published: (2015)

Discovering the molecular basis for ligand pharmacological activity on β-adrenoceptors
by: Bunsuz, Asuman
Published: (2023)

Self-polymerization of dopamine-coated zinc oxide as a potential antibacterial nanoparticle with molecular docking analysis
by: Albarqouni, Yasin M.Y., et al.
Published: (2025)

Structure–activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor
by: Shonberg, Jeremy, et al.
Published: (2015)

The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials.
by: Pezze, Marie A., et al.
Published: (2016)